ANG Lifesciences Fair Value
ANG Lifesciences (ANG) average fair value is ₹71.67 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹32.65 (+119.52%), fair value range ₹40.77–₹112.12. For live price and a broader fundamental view, visit ANG Lifesciences share price chart.
Fair Value Analysis Export
ANG Fair Value vs Current Price — Valuation Summary
ANG average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
ANG Fair Value Analysis — Data Sources & Coverage
ANG Lifesciences financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. Check ANG company valuation to track the company's total market size over time.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
ANG vs Healthcare Sector Peers — P/E, P/B & Market Cap
ANG Lifesciences P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Jeena Sikho Lifecare | JSLL | 33.24 | 15.78 | ₹7,371 |
| Sat Kartar Life | SATKARTAR | 13.44 | 3.4 | ₹226 |
| KRM Ayurveda | KRMAYURVED | - | 4.56 | ₹545 |
| Emcure Pharmaceuticals | EMCURE | 37.24 | 7.08 | ₹34,821 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.